Prostate Cancer Incidence, Mortality Rates Mainly Stable, Decreasing

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Dec. 11, 2024 -- In most countries, prostate cancer incidence and mortality rates decreased or were stable in the most recent five-year period, but increasing trends were seen in some countries, according to a study published online Dec. 11 in European Urology.

Elizabeth J. Schafer, M.P.H., from the American Cancer Society in Atlanta, and colleagues examined worldwide patterns and trends in prostate cancer incidence and mortality using data from the Cancer Incidence in Five Continents series and the World Health Organization mortality database.

The researchers found that the estimated prostate cancer rates varied 13-fold for incidence and 9.5-fold for mortality across regions in 2022, with the highest incidence rates seen in Australia/New Zealand, North America, Northern Europe, and Latin America and the Caribbean, and the highest mortality rates seen in sub-Saharan Africa and Latin America and the Caribbean. During the most recent five-year period, incidence and mortality rates increased in 11 of 50 countries and nine of 59 countries included in the study, respectively, mostly in Africa, Asia, Latin America and the Caribbean, and Central and Eastern Europe. In 38 countries, there were decreases observed in mortality rates, mainly in Europe, Oceania, and Latin America and the Caribbean.

"These findings reinforce the need for improvements in access to early detection and treatment services to mitigate the undue high burden of the disease in these countries," the authors write. "Furthermore, improvements in data availability and quality, particularly in low- and middle-income countries in Asia and Africa, will enhance our understanding of current disparities and prioritization of early detection and treatment approaches."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-12 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords